Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment (Q40163305)

18 September 2017

Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment (English)

1 reference

18 September 2017

1 reference

Shuchi Mittal

1

1 reference

18 September 2017

Deepti Dubey

series ordinal

2

1 reference

18 September 2017

Kazuhiro Yamakawa

series ordinal

3

1 reference

18 September 2017

Subramaniam Ganesh

series ordinal

4

1 reference

18 September 2017

2 March 2007

1 reference

18 September 2017

Human Molecular Genetics

1 reference

18 September 2017

16

1 reference

18 September 2017

7

1 reference

18 September 2017

753-762

1 reference

Advances in the genetics of progressive myoclonus epilepsy

18 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

LAFORA'S DISEASE. DISTINCT CLINICO-PATHOLOGIC FORM OF UNVERRICHT'S SYNDROME.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Mutations in NHLRC1 cause progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

The role of ubiquitin-protein ligases in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

The aggravating role of the ubiquitin-proteasome system in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Ubiquitin-protein ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Lewy-body formation is an aggresome-related process: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Ubiquitin-proteasome system and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Parkin accumulation in aggresomes due to proteasome impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Parkin is recruited to the centrosome in response to inhibition of proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Aggresomes: a cellular response to misfolded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Expanding insights of mitochondrial dysfunction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Aggresomes, inclusion bodies and protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Hassles with taking out the garbage: aggravating aggresomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Pericentrin, a highly conserved centrosome protein involved in microtubule organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Dynamic association of proteasomal machinery with the centrosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

γ-Tubulin is a highly conserved component of the centrosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Cytoplasmic dynein/dynactin mediates the assembly of aggresomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

A novel action of histone deacetylase inhibitors in a protein aggresome disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3beta phosphorylation, and Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

A chloroplast-localized dual-specificity protein phosphatase in Arabidopsis contains a phylogenetically dispersed and ancient carbohydrate-binding domain, which binds the polysaccharide starch

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Biochemical studies on tissues from a patient with lafora disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Glycogen metabolism in tissues from a mouse model of Lafora disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

21 January 2018

Identifiers

DOI

10.1093/HMG/DDM006

1 reference

18 September 2017

1 reference